Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Eli Lilly

since

auto-detected in 128 stories

37 hours ago

Daily orforglipron tablets led to greater weight loss than semaglutide tablets, offering potential oral alternative to Wegovy and Mounjaro

A new daily pill could be a more effective GLP-1 tablet for w…

2 days ago

Thanks to its “best-in-class” status, the bank believes the company will be the winner from a growing GLP-1 patient base.

3 days ago

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lilly’s Zepbound.

4 days ago

President Trump is raising his threatened global tariff to 15%, and Eli Lilly triumphs over obesity rival Novo Nordisk once again.
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target.

12 days ago

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade

“I just felt slow: I want to be able to do anything my kids want to do and not have weight b…

22 days ago

Weight-loss and fertility medicines sold by Novo Nordisk, Eli Lilly, EMD and others will be included on the discount medicine site

23 days ago

These are the stocks posting the largest moves in premarket trading.
Combined sales for the company's blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing triple-digit growth.

28 days ago

AMD, Alphabet and Amazon are among the heavyweight companies reporting earnings in the week ahead.

page 1 of 13 last →|